Kyntra Bio
KYNB
118 hedge funds and large institutions have $629M invested in Kyntra Bio in 2015 Q3 according to their latest regulatory filings, with 32 funds opening new positions, 46 increasing their positions, 26 reducing their positions, and 10 closing their positions.
220% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 10
77% more repeat investments, than reductions
Existing positions increased: 46 | Existing positions reduced: 26
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
23% more funds holding
Funds holding: 96 → 118 (+22)
6% more capital invested
Capital invested by funds: $593M → $629M (+$36.1M)
3% less call options, than puts
Call options by funds: $2.17M | Put options by funds: $2.25M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$23.2M |
| 2 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$19M |
| 3 |
VAM
Visium Asset Management
New York
|
+$10.7M |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$9.4M |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
+$9.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$21.6M |
| 2 |
HLA
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
|
-$5.79M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$5.38M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$4.45M |
| 5 |
Lazard Asset Management
New York
|
-$4.21M |
KYNB Hedge Fund Activity: Q3 2015 in Review
118 of the 3,589 institutional investors tracked by Wall St. Rank reported a position in Kyntra Bio (KYNB) for Q3 2015, worth a combined $629M — up 6.1% from $593M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new KYNB positions and 10 closed out — a net gain of 22 holders — while 46 added to existing stakes and 26 trimmed.
The largest buyer was Vanguard Group, adding an estimated $23.2M. The largest seller was Franklin Resources, cutting an estimated $21.6M.
- 118 institutional investors held Kyntra Bio (KYNB) as of Q3 2015, up from 96 in Q2 2015.
- Funds reported $629M of Kyntra Bio stock for Q3 2015, up 6.1% quarter-over-quarter.
- 32 funds opened new Kyntra Bio positions in Q3 2015 and 10 closed out, a net change of +22 holders.
- The largest Kyntra Bio buyer in Q3 2015 was Vanguard Group, an estimated $23.2M added.
- The largest Kyntra Bio seller in Q3 2015 was Franklin Resources, an estimated $21.6M sold.
Based on aggregated 13F filings for Q3 2015.